Back

Aspirin in primary prevention. Risks and benefits. Up date 2019. A meta-analysis

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding Cardiovascular Risk Assessment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Lorenzo Martin Lobo

Education Administration - Argentine Army, Buenos Aires (Argentina)

12 More presentations in this session

Presentation thumbnail
Doctor I. Hammami (Oxford, GB)
Abstract
Presentation thumbnail
Doctor A. Conti (Massa, IT)
Abstract Slides
Presentation thumbnail
Doctor A. Baluja (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Doctor A. Katbeh (Damascus, SY)
Abstract Slides
Presentation thumbnail
Professor D. Linz (Maastricht, NL)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources